Disease | cutaneous t cell lymphoma |
Comorbidity | C0085110|severe combined immunodefic |
Sentences | 1 |
PubMedID- 20501616 | In a severe combined immunodeficient-beige mouse model of transformed cutaneous t-cell lymphoma, the addition of pralatrexate to bortezomib enhanced efficacy compared with either drug alone. |
Page: 1